Search

everythinglearnresearchcommunity

for

Search:↓

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

FoxN1 overexpression in young mice harms immune cell and skin development.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Mitf plays a key role in melanoma progression and is linked to disease stage.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

HPV8 E6 gene causes growth of certain skin stem cells.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

A rare EGFR mutation in newborns leads to severe health issues and early death.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Erlotinib can cause hair loss as a side effect.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Loss of TET2 increases the risk of skin and oral cancer.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.